|Day Low/High||49.85 / 50.40|
|52 Wk Low/High||54.75 / 81.82|
CFO Dominic Caruso said on an earnings call that ongoing reviews of the company's portfolio "suggest we currently have more opportunity to divest some nonstrategic businesses."
Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.
SurgiMend MP is a collagen matrix for soft tissue reconstruction, featuring a highly macroporous design
Financing now secured for the planned acquisition of Codman Neurosurgery
Dr. Reddy's Laboratories Limited (BSE:500124, NSE:DRREDDY, NYSE:RDY) and Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that they have entered into an...
2016 Results and 2017 Guidance in line with January 10, 2017 Preliminary Announcement
Integra hopes this deal will grow its revenue to $2 billion sooner than expected.
The company hopes the JNJ assets will give revenue growth a boost.
The company's shares hit $6.95 Wednesday midday.